Bio

Carolyn Horn joined Needham & Company in 2015. She was appointed Co-Head of Needham’s Healthcare Investment Banking Group in January 2021. Prior to joining the healthcare banking team, she led the Healthcare Equity Capital Markets group for four years, and has overseen the origination and execution of all life sciences equities transactions. With a focus on emerging growth companies, Carolyn advises on both public and private financings including IPOs, follow-on offerings, convertible debt, and private placements. She has completed over 200 life sciences equity transactions over the course of her career. Previously, Carolyn was the Healthcare Specialist in Institutional Sales at JMP Securities, focusing on the biotech, medtech, and specialty pharmaceuticals sectors. Earlier in her career, she worked with a healthcare financial services firm in New York, and in the Emerging Companies group at the Biotechnology Innovation Organization (BIO) in Washington DC. Carolyn earned her undergraduate degree from Washington University in St. Louis.